Home/Hexagon Bio/Maureen Hillenmeyer, PhD

MH

Maureen Hillenmeyer, PhD

Chief Executive Officer & Co-Founder

Therapeutic Areas

Hexagon Bio Pipeline

Drug	Indication	Phase
Undisclosed ADC Programs	Oncology (Resistant Cancers)	Pre-clinical

Leadership Team at Hexagon Bio

Tara Arvedson, PhD

Chief Scientific Officer

Bill Grossman, MD, PhD

Chief Medical Officer

Kunal Patel, MBA

Senior Vice President, Business Development

View full Hexagon Bio profile